Johnson & Johnson and Roche are among the companies best positioned to take advantage of future cybersecurity disruption in the medical devices industry, our analysis shows.
The assessment comes from GlobalData’s Thematic Research ecosystem, which ranks companies on a scale of one to five based on their likelihood to tackle challenges like cybersecurity and emerge as long-term winners of the medical devices sector.
According to our analysis, Johnson & Johnson is the company best positioned to benefit from investments in cybersecurity, the only company with a score of five out of five in GlobalData’s Medical Devices Thematic Scorecard.
